ATTORNEY ADVERTISEMENT. Samuel L. Eilers, Esq. (CA SBN 289222), 3099 Driscoll Drive, San Diego, CA 92117
Advertising by a legal marketing service. No attorney-client relationship is formed.
Oxbryta Recall Lawsuit
Oxbryta sickle cell drug recalled after reports of deaths and complications. Patients may have claims.
Intake criteria and litigation status are summarized below.
Results vary. Past results do not guarantee future outcomes. No compensation is guaranteed.
Symptoms & Injuries
- Vaso-occlusive crisis
- Fatal complications
- Organ damage
- Severe anemia events
Intake Criteria
- • Took Oxbryta ( voxelotor )
- • Serious injury or death of loved one
- • Use before 2024 recall
Lawsuit Updates
2024
Post-recall litigation emerging
Claims developing following FDA safety alerts and recall.
MDL Information
- Court
- Emerging
- Docket
- Pending
- Filed
- 2024
- Overview
- Oxbryta sickle cell drug injury claims.
FAQ
Relevant information may include Oxbryta use or exposure, related injuries, usage duration, diagnosis, and state-specific deadlines.